Circumvent


Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease.

Industries

Employees

1-10

Links


Org chart

Collapse
Daniel Chelsky
Chief Scientific Officer

Teams

This company has no teams yet


Offices